Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ENTX
#3424
Entera Bio Ltd. Ordinary Shares
1.3
9
-8.55%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-8.55%
Monthly Change
-11.46%
6 month change
-30.15%
Year Change
-27.60%
Previous Close
1.5
2
Open
1.3
9
Bid
Ask
Low
1.3
9
High
1.3
9
Volume
2
Markets
US Stock Market
Healthcare
ENTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
TTM
Cash from operating activities
10.42 M
9.06 M
12.5 M
7.31 M
6.82 M
7 M
Cash from investing activities
86 K
17 K
102 K
17 K
3 000
83 K
Cash from financing activities
3.92 M
25.38 M
13 K
6.04 M
4.48 M
16.75 M
Free cash flow
10.42 M
9.05 M
12.45 M
7.29 M
6.82 M
6.92 M
News
What Pushed Entera Bio (ENTX) To Rally Nearly 16% After Hours - Entera Bio (NASDAQ:ENTX)
Opko Health stock rating reiterated at Buy by H.C. Wainwright
Entera Bio appoints Geno Germano as board chairman
OPKO and Entera expand collaboration to develop oral PTH treatment
Entera Bio plans FDA submission for osteoporosis drug in Q1 2026
H.C. Wainwright reiterates Buy rating on Entera Bio stock as FDA qualifies BMD endpoint
Entera Bio’s oral PTH analog shows sustained calcium response
Entera Bio stock rises after positive Phase 2 bone density data
Entera Bio reports positive data for oral osteoporosis treatment
Entera Bio stock rating reiterated at Buy by H.C. Wainwright
Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy
Entera Bio presents promising data for oral GLP-2 treatment for SBS